We observed that p53 was upregulated while AR and AR-V7 was downregulated in prostate cancer cells treated with these two inhibitors, indicating that the repressive effect of RNase H2 activity is responsible for gene regulation. The gene discussed is TP53; the disease is Familial prostate cancer.